AU7516898A - Peripheral benzodiazepine receptor ligands - Google Patents

Peripheral benzodiazepine receptor ligands

Info

Publication number
AU7516898A
AU7516898A AU75168/98A AU7516898A AU7516898A AU 7516898 A AU7516898 A AU 7516898A AU 75168/98 A AU75168/98 A AU 75168/98A AU 7516898 A AU7516898 A AU 7516898A AU 7516898 A AU7516898 A AU 7516898A
Authority
AU
Australia
Prior art keywords
receptor ligands
benzodiazepine receptor
peripheral benzodiazepine
peripheral
ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75168/98A
Inventor
Andis Klegeris
Edith G. Mcgeer
Patrick L Mcgeer
J. Douglas Waterfield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Publication of AU7516898A publication Critical patent/AU7516898A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU75168/98A 1998-05-22 1998-05-22 Peripheral benzodiazepine receptor ligands Abandoned AU7516898A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA1998/000502 WO1999061024A1 (en) 1998-05-22 1998-05-22 Peripheral benzodiazepine receptor ligands

Publications (1)

Publication Number Publication Date
AU7516898A true AU7516898A (en) 1999-12-13

Family

ID=4173300

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75168/98A Abandoned AU7516898A (en) 1998-05-22 1998-05-22 Peripheral benzodiazepine receptor ligands

Country Status (5)

Country Link
EP (1) EP1077702A1 (en)
JP (1) JP2002516279A (en)
AU (1) AU7516898A (en)
CA (1) CA2332825A1 (en)
WO (1) WO1999061024A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004518611A (en) * 2000-07-27 2004-06-24 ファルマシア・コーポレーション Aldosterone blocker therapy to prevent or treat inflammation-related disorders
US20050009812A1 (en) * 2001-10-05 2005-01-13 Takuya Seko Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
JP4362457B2 (en) 2005-04-26 2009-11-11 独立行政法人科学技術振興機構 Neuropathic pain treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091381A (en) * 1991-04-12 1992-02-25 Biomeasure, Inc. 2H-1,3,4-benzotriazepin-2-ones

Also Published As

Publication number Publication date
CA2332825A1 (en) 1999-12-02
EP1077702A1 (en) 2001-02-28
WO1999061024A1 (en) 1999-12-02
JP2002516279A (en) 2002-06-04

Similar Documents

Publication Publication Date Title
AU1199600A (en) Estrogen receptor ligands
AU7321698A (en) Vehicular rotary seat
AU3615599A (en) Melanocortin receptor ligands
AU2089899A (en) Improved seat cover
AU1548300A (en) Seat
AUPP278498A0 (en) Peripheral benzodiazepine receptor binding agents
AU6928698A (en) Service creation
AU6804098A (en) Triazinylaminostilbene compounds
AU8096798A (en) Dopamine d4 receptor ligands
AU7132898A (en) Edg-1-like receptor
AU7476598A (en) 18-substituted-19-nor-vitamin d compounds
AU5293698A (en) Mat
AU7450898A (en) Indole compounds
AU2248195A (en) Opiate receptor ligands
AU7124598A (en) Polymer-platinum compounds
AUPP042397A0 (en) 5-arylpyrazole compounds
AU5671699A (en) Grp receptor ligands
AU6913100A (en) Notch receptor ligands and uses thereof
AUPO938697A0 (en) Novel receptor
GB9715815D0 (en) Histamine H receptor ligands
EP1028947B8 (en) H3 receptor ligands of the phenyl-alkyl-imidazoles type
AU8851798A (en) Saddle underlay
AU7516898A (en) Peripheral benzodiazepine receptor ligands
AU9546898A (en) Multi-layered renovative pipeliner
AU8019998A (en) Fluoromethoximino compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase